Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Neoplasms × Pregabalin × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 2 Persistent Postoperative Pain 1 Neuralgia 1 Neoplasms 1 Lymphoma, Follicular 1 Hot Flashes 1 Chronic Pain 1 Breast Neoplasms 1 Breast Cancer Patient 1 Acute Pain 1

Interventions

Paclitaxel 20 Dexamethasone 16 Bevacizumab 16 Gemcitabine 15 Docetaxel 15 Oxaliplatin 14 Cyclophosphamide 13 Carboplatin 12 Capecitabine 12 Sorafenib 11 Leucovorin 10 Fluorouracil 10 Pemetrexed 9 Epoetin Alfa 9 Cisplatin 9 venetoclax 8 pembrolizumab 8 Prednisone 8 Fentanyl 8 Drug Therapy 8 Doxorubicin 8 atezolizumab 7 Rivaroxaban 7 Rituximab 7 Darbepoetin alfa 7 Anastrozole 7 Panitumumab 6 Ondansetron 6 Morphine 6 Irinotecan 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00740571 2009-02-05

Off-label

Radboud University Medical Center

Phase 3 Unknown

Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡